Aspirin
- Product NDC
- 0363-0157
- 11-digit product format
- 003630157
- Labeler code
- 0363
- Product ID
- 0363-0157_73dce3e7-b83d-4318-94b4-eefbeb45ba6b
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Aspirin
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Walgreen Company
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 1996-02-10
- Substance
- ASPIRIN
- Active strength
- 325 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 0363-0157 | 0363-0157-12 | D | Discontinued by firm | 2026-09-14 | |
| excluded package | package | 0363-0157 | 0363-0157-17 | D | Discontinued by firm | 2026-09-14 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | 0363-0157-12 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 0363-0157-17 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 0363-0157-12 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 0363-0157-17 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 0363-0157-12 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 0363-0157-17 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 0363-0157-12 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 0363-0157-17 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 0363-0157-12 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 0363-0157-17 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 0363-0157-12 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 0363-0157-17 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 0363-0157-12 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 0363-0157-17 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 0363-0157-12 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 0363-0157-17 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0363-0157-12 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0363-0157-17 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 0363-0157-12 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 0363-0157-17 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 0363-0157-12 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 0363-0157-17 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 0363-0157-12 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 0363-0157-17 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Aspirin
- Brand name suffix
- Regular Strength
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ASPIRIN | 325 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| R16CO5Y76E | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 212033 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 0b27c0fd-7ea8-4588-9169-5ad4e8df77ef | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d7724692-1155-4cc8-a415-22f5fc4aec35 | Product name | 6 | 20220216 |
| bde672ba-4805-28d0-1986-73543d41b412 | Product name | 2 | 20210201 |
| f212291f-05fe-9603-fc7e-bd73e38ce1e6 | Product name | 2 | 20161129 |
| ade821ba-260a-47e2-bd89-743e27ac9906 | Product name | 1 | 20161121 |
| 182f9ab4-4ab5-c449-200f-87ce2ce8e550 | Product name | 2 | 20151105 |
| 9425d234-4ae1-4b53-adc6-8cc7af6dd657 | Product name | 1 | 20150929 |
| 2a21311a-89e2-0e83-2ebd-117f9798b2b2 | Product name | 1 | 20140508 |
| 9007e8a7-ff50-f9b9-7945-f2a1deadd94e | Product name | 1 | 20140508 |
| 96c2be53-8e44-452d-56a2-d255b2f1af2d | Product name | 1 | 20140508 |
| bf8bd5f7-495f-4022-2780-7ded7ea7ea44 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0363-0157-12 | AspirinRegular Strength | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 18 | |
| 0363-0157-12 | AspirinRegular Strength | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 18 | |
| 0363-0157-14 | AspirinRegular Strength | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 18 | |
| 0363-0157-17 | AspirinRegular Strength | 300 in 1 BOTTLE | TABLET, FILM COATED | 300 | 18 | |
| 0363-0157-98 | AspirinRegular Strength | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 18 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0363-0157-12 | EA - Each | 0363-0157 | c1df263e-160b-44c3-846e-1b47026abbd2 | 1 | 2013-07-02 |
| 0363-0157-14 | EA - Each | 0363-0157 | 3fa3e4c3-88ca-4555-ac59-97f896a4ff49 | 1 | 2013-07-02 |
| 0363-0157-17 | EA - Each | 0363-0157 | 9be46883-8972-492d-8925-4fcbd1e7cd21 | 1 | 2013-07-02 |
| 0363-0157-98 | EA - Each | 0363-0157 | 71183431-ecba-4ae7-a730-70e6729f3f60 | 1 | 2015-07-20 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ASPIRIN | ACTIVE INGREDIENT | R16CO5Y76E | ASPIRIN REGULAR STRENGTH (ASPIRIN) TABLET, FILM COATED [WALGREEN CO.] | 3 | |
| ASPIRIN | ACTIVE MOIETY | R16CO5Y76E | ASPIRIN REGULAR STRENGTH (ASPIRIN) TABLET, FILM COATED [WALGREEN CO.] | 3 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | ASPIRIN REGULAR STRENGTH (ASPIRIN) TABLET, FILM COATED [WALGREEN CO.] | 3 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | ASPIRIN REGULAR STRENGTH (ASPIRIN) TABLET, FILM COATED [WALGREEN CO.] | 3 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | ASPIRIN REGULAR STRENGTH (ASPIRIN) TABLET, FILM COATED [WALGREEN CO.] | 3 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | ASPIRIN REGULAR STRENGTH (ASPIRIN) TABLET, FILM COATED [WALGREEN CO.] | 3 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 212033 | aspirin 325 MG Oral Tablet | PSN | 0b27c0fd-7ea8-4588-9169-5ad4e8df77ef | 18 |
| 212033 | aspirin 325 MG Oral Tablet | SCD | 0b27c0fd-7ea8-4588-9169-5ad4e8df77ef | 18 |
| 212033 | ASA 325 MG Oral Tablet | SY | 0b27c0fd-7ea8-4588-9169-5ad4e8df77ef | 18 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0363-0157-12 | 00363015712 | 1 BOTTLE in 1 CARTON (0363-0157-12) > 100 TABLET, FILM COATED in 1 BOTTLE | 1 bottle | 1996-02-10 | 2021-03-19 | No | No | Current |
| 0363-0157-14 | 00363015714 | 500 TABLET, FILM COATED in 1 BOTTLE (0363-0157-14) | 1996-02-10 | 0000-00-00 | No | No | Current | |
| 0363-0157-17 | 00363015717 | 300 in 1 BOTTLE | Historical | |||||
| 0363-0157-98 | 00363015798 | 100 TABLET, FILM COATED in 1 BOTTLE (0363-0157-98) | 1996-02-10 | 0000-00-00 | No | No | Current |